Finance

Lists
Why is HURA down 4,14%?
Dive Deeper
HURA:NASDAQ
TuHURA Biosciences Inc
1,39 USD
-4,14%
(-0,060) 1D
13-ноя., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HURA...
Open
1,51 USD
High
1,53 USD
Low
1,36 USD
Mkt. cap
88,58 млн
Avg. vol.
410,38 миң
Volume
371,86 миң
52-wk high
3,41 USD
52-wk low
0,41 USD
EPS
-0,54 USD
Beta
-0,23
Shares outstanding
63,73 млн
No. of employees
22
Open
1,51 USD
High
1,53 USD
Low
1,36 USD
Mkt. cap
88,58 млн
Avg. vol.
410,38 миң
Volume
371,86 миң
52-wk high
3,41 USD
52-wk low
0,41 USD
EPS
-0,54 USD
Beta
-0,23
Shares outstanding
63,73 млн
No. of employees
22
News stories
From web sources and news partners
About TuHURA Biosciences Inc
CEO-
Employees22
Founded1995
HeadquartersТампа, Флорида, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitetuhurabio.com
Analyst ratings
Based on 2 analysts giving stock ratings to HURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for HURA in the last 3 months.
Highest
Current 1,39 USD
10,00 USD (+619,42%)
Average
9,00 USD (+547,48%)
Lowest
8,00 USD (+475,54%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
10,00 USD
+619,4%
10/27/2026
Jason McCarthy
Maxim Group
Buy
Maintained
8,00 USD
+475,5%
08/25/2026
Silvan Turkcan
Citizens JMP
Buy
Initiated
9,00 USD
+547,5%
04/27/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
9,00 USD
+547,5%
04/27/2026
Michael King
Rodman & Renshaw
Buy
Initiated
7,00 USD
+403,6%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,97 млн
6,06 млн
5,23 млн
6,62 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,76 млн
2,34 млн
2,30 млн
2,14 млн
Operating expense
6,73 млн
8,39 млн
7,53 млн
8,76 млн
Total operating expenses
6,73 млн
8,39 млн
7,53 млн
8,76 млн
Operating income
-6,73 млн
-8,39 млн
-7,53 млн
-8,76 млн
Other non operating income
-46,72 миң
185,02 миң
-
-
EBT including unusual items
-7,10 млн
-6,76 млн
-7,54 млн
-9,22 млн
EBT excluding unusual items
-6,79 млн
-8,82 млн
-7,54 млн
-9,22 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,10 млн
-6,76 млн
-7,54 млн
-9,22 млн
Net profit margin
-
-
-
-
Earnings per share
-0,14
-0,16
-0,13
-
Interest and investment income
6,06 миң
609,00
21,28 миң
7,62 миң
Interest expense
-16,53 миң
-608,75 миң
-27,97 миң
-467,63 миң
Net interest expenses
-10,47 миң
-608,14 миң
-6,70 миң
-460,01 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,71 млн
-8,37 млн
-7,51 млн
-8,74 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору